GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA
Patient 3
11
mild
499
IgM
Patient 3
11
mild
122
IgA
Patient 1
10
moderate
388
IgM
Patient 3
-180
mild
8125
IgM
Patient 1
10
moderate
37
IgM
Patient 2
24
mild
243
IgM
Patient 3
4
mild
267
IgG
Patient 1
10
moderate
46
IgA
Patient 2
3
mild
1022
IgM
Patient 2
3
mild
241
Displaying entries 1 - 10 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01